Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Borner

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Molecular targets in colon cancer]M M Borner
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancerM M Borner, M Bacchi, M Castiglione
Biochimica Et Biophysica Acta|November 20, 1997
Type of inducing signal regulates transactivation by p53M M Borner, F Joncourt, M A Hotz
British Journal of Cancer|January 1, 1997
Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cellsM M Borner, F Joncourt, M A Hotz
Anticancer Research|May 1, 1995
Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistanceH E Eliot, M M Borner, B K Sinha
Cell Death and Differentiation|August 16, 2002
Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathwayF Pirnia, E Schneider, D C Betticher, et al.
The Journal of Clinical Investigation|December 1, 1992
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell linesO Sartor, C A McLellan, C E Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Activity of raltitrexed and gemcitabine in advanced pancreatic cancerE Kralidis, S Aebi, H Friess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devicesD Zahnd, S Aebi, S Rusterholz, et al.
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Molecular targets in colon cancer]M M Borner
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancerM M Borner, M Bacchi, M Castiglione
Biochimica Et Biophysica Acta|November 20, 1997
Type of inducing signal regulates transactivation by p53M M Borner, F Joncourt, M A Hotz
British Journal of Cancer|January 1, 1997
Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cellsM M Borner, F Joncourt, M A Hotz
Anticancer Research|May 1, 1995
Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistanceH E Eliot, M M Borner, B K Sinha
Cell Death and Differentiation|August 16, 2002
Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathwayF Pirnia, E Schneider, D C Betticher, et al.
The Journal of Clinical Investigation|December 1, 1992
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell linesO Sartor, C A McLellan, C E Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Activity of raltitrexed and gemcitabine in advanced pancreatic cancerE Kralidis, S Aebi, H Friess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devicesD Zahnd, S Aebi, S Rusterholz, et al.
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Pageof 4